Ionizing radiation induces production of tumor necrosis factor α in the ewing's sarcoma cell line RM 82 in vitro and in vivo;Nachweis einer strahleninduzierten produktion von tumor-nekrose-faktor alpha im ewing-sarkom RM 82 in vitro und in vivo

Strahlentherapie und Onkologie

Volumn 173, Issue 8, 1997, Pages 407-414

  Rube C ^a,b   Finke, C ^a   Van Valen, F ^a   Schafer K L ^a   Dockhorn Dworniczak, B ^a   Willich, N ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Ewing's sarcoma; Ionizing radiation; TNF expression; TNF mRNA; Xenografi tumor

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DOSE TIME EFFECT RELATION; EWING SARCOMA; IONIZING RADIATION; NONHUMAN; PROTEIN SYNTHESIS REGULATION; RADIATION DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030803956     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038316     Document Type: Article

References (53)

1. Barbuto, A. J., E. M. Hersh: Role of cytokines in cancer therapy. In: Aggarwal, B. B., R. K. Puri (eds.): Human cytokines: Their role in disease and therapy. Blackwell Science, Cambridge, USA 1995, p. 503-524.
2. Bertolini, D. R., G. E. Nedwin, T. S. Bringman: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature (Lond.) 319 (1986), 516-518.
3. Carswell, E. A., I. L. J. Old, R. L. Kassel: An endotoxin induced serum factor which causes necrosis of tumors. Proc. nat. Acad. Sci. (Wash.) 72 (1975), 3666-3670.
4. Chomczynski, P., N. Sacchi: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987), 156-159.
5. Creasy, A. A., M. T. Reynolds, W. Laird: Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Cancer Res. 46 (1986), 5687-5690.
6. Dockhorn-Dworniczak, B., C. Poremba, R. Dantcheva: Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms. Virchows Arch., A 424 (1994), 337-342.
7. Dockhorn-Dworniczak, B., S. Schröder, R. Dantcheva: The role of p53 tumor suppressor gene in human thyroid cancer. Exp. clin. Endocr. 101 (1993), 39-46.
8. Doukas, M. A., V. Gallicchio: Role of cytokines in modulation of radiation injury. In: DeVita, V. T., S. Hellman, S. A. Rosenberg (eds.): Biologic therapy of cancer. Lippincott, Philadelphia 1995, p. 565-582.
9. Fiers, W.: Biologic therapy with TNF: Preclinical studies. In: DeVita, V. T., S. Hellman, S. A. Rosenberg (eds.): Biologic therapy of cancer. Lippincott, Philadelphia 1995, p. 295-328.
10. Fraker, D. I., H. R. Alexander, H. I. Pass: Biologic therapy with TNF: Systemic administration and isolation-perfusion. In: DeVita, V. T., S. Hellman, S. A. Rosenberg (eds.): Biologic therapy of cancer. Lippincott, Philadelphia 1995, p. 329-346.
11. Fransen, L., D. H. J. Van, R. Ruysschaert: Recombinant tumor necrosis factor: Its effects and synergism with interferon-gamma on a variety of normal and transformed human cell lines. Europ. J. Cancer clin. Oncol. 22 (1986), 419-426.
12. Goldmann, D., C. R. Merril: Silver staining of DNA in polyacrylamid gels: Linearity and effect of fragment size. Electrophoresis 3 (1992), 24-26.
13. Gridley, D. S., S. N. Hammond, B. H. Liwnicz: Tumor necrosis factor-α augments radiation effects against human colon tumor xenografts. Anticancer Res. 14 (1994), 1107-1112.
14. Hallahan, D. E., M. A. Beckett, D. Kufe: The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 19 (1990), 69-74.
15. Hallahan, D. E., A. Haimouits-Friedman, D. W. Kufe, Z. Fuks, R. R. Weichselbaum: The role of cytokines in radiation oncology. In: DeVita, V. T., S. Hellman, S. A. Rosenberg (eds.): Important advances in oncology 1993. Lippincott, Philadelphia 1993, p. 71-80.
16. Hallahan, D. E., D. R. Spriggs, M. A. Beckett: Increased tumor necrosis factor α mRNA after cellular exposure to ionizing radiation. Proc. nat. Acad. Sci. (Wash.) 86 (1989), 10104-10107.
17. Hand, A. M., K. Husgafvel Pursiainen, L. Temmilehto: Malignant mesothelioma: The antiproliferative effect of cytokine combinations on three human mesothelioma cell lines. Cancer Lett. 58 (1991), 205-210.
18. Haranaka, K., N. Satomi: Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro. Jap. J. exp. Med. 51 (1981), 191-194.
19. Hersh, E. M., B. S. Metch, F. M. Muggia: Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: A summary of the Southwest Oncology Group experience. J. Immunother. 10 (1991), 426-431.
20. Larrick, J. W., S. Wright: Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 4 (1990), 3215-3223.
21. Lattime, E. C., A. Stoppacciaro, A. Khan: Human natural cytotoxic activity mediated by tumor necrosis factor: Regulation by interleukin-2. J. nat. Cancer Inst. 80 (1988), 1035-1038.
22. Leibovich, S. J.: Role of cytokines in the progress of tumor angiogenesis. In: Aggarwal, B. B., R. K. Puri (eds.): Human cytokines: Their role in disease and therapy. Blackwell Science, Cambridge, USA 1995, p. 539-564.
23. Leibovich, S. J., P. J. Polverini, H. M. Shepard: Macrophage-induced angiogenesis is mediated by tumor necrosis factor alpha. Nature (Lond.) 329 (1987), 630-632.
24. Lejeune, F. J.: High dose recombinant tumour necrosis factor (rTNFα) administered by isolation perfusion for advanced tumours of the limbs: A model for biochemotherapy of cancer. Europ. J. Cancer 31A (1995), 1009-1016.
25. Lugassy, C., J. P. Escande: Immunolocation of TNF-α/cachectin in human melanoma cells: Studies on co-cultivated malignant melanoma. J. invest. Derm. 96 (1987), 238-242.
26. McBride, W. H., J. S. Economou, N. Kuber, J.-H. Hong, C.-S. Chiang, R. Syljuasen, S. T. Dougherty, G. J. Dougherty: Modification of tumor microenvironment by cytokine gene transfer. Acta oncol. 34 (1995), 447-451.
27. Müller, H., M. Takeshita, J. Krause, K. Schuster, M. Kihuchi, H. J. Stutte: Immunhistochemischer in situ-Nachweis von Zytokinen in Hodgkin- und Non-Hodgkin-Lymphomen. Verh. dtsch. Ges. Path. 76 (1992), 164-168.
28. Mullis, K. B., F. A. Faloona: Specific synthesis of DNA in vitro via a polymerase catalysed chain reaction. Meth. Enzymol. 155 (1987), 335-350.
29. Naylor, M. S., S. T. A. Malik, G. W. H. Stamp: In situ detection of tumor necrosis factor in human ovarian cancer specimens. Int. J. Cancer 26 (1990), 1027-1030.
30. Nishiguchi, I., V. Willingham, L. Milas: Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors. Int. J. Radiat. Oncol. Biol. Phys. 18 (1989), 555-558.
31. Old, L. J.: Antitumor activity of microbial products and tumor necrosis factor. In: Bonavida, B., G. E. Gifford, H. Kirchner, L. J. Old (eds.): Tumor necrosis factor/cachectin and related cytokines. Karger, Basel 1988, p. 7-19.
32. Parks, R. R., S. D. Yan, C. C. Huang: Tumor necrosis factor-alpha production in human head and neck squamous cell carcinoma. Laryngoscope 104 (1994), 860-864.
33. Rashtchian, A.: Amplification of RNA. PCR Meth. and Appl. 4 (1994), 583-591.
34. Rinehart, J., S. P. Balcerzak, M. E. Hersh: Phase II trial of tumor necrosis factor in human sarcoma. Proc. Amer. Soc. clin. Oncol. 9 (1990), 317.
35. Rodemann, H. P., M. Bamberg: Cellular basis of radiation-induced fibrosis. Radiother. Oncol. 35 (1995), 83-90.
36. Schaadt, M., M. Pfreundschuh, G. Lorscheidt: Phase II-study of recombinant human tumor necrosis factor in colorectal carcinoma. J. biol. Response Modif. 9 (1990), 247-250.
37. Sersa, G., V. Willinghara, L. Milas: Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy. Int. J. Cancer 42 (1988), 129-134.
38. Shimomura, K., T. Manda, S. Mukumoto: Recombinant human tumor necrosis factor-alpha; thrombus formation is a cause of antitumor activity. Int. J. Cancer 41 (1988), 243-247.
39. Skillings, J., R. Wierzbicki, E. Eisenhauer: A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: A study of the National Cancer Institute of Canada Clinical Trials Group. J. Immunother. 11 (1992), 67-70.
40. Suematsu, S., T. Kishimoto: Autocrine and paracrine role of cytokines as growth factors for tumor genesis. In: Aggarwal, B. B., R. K. Puri (eds.): Human cytokines: Their role in disease and therapy. Blackwell Science, Cambridge, USA 1995, p. 525-538.
41. Sugarman, B. J., B. B. Aggarwal, P. E. Hass: Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro. Science 230 (1985), 943-945.
42. Takeyama, H., N. Wakamiya, C. O'Hara: Tumor necrosis factor expression by human ovarian carcinoma in vivo. Cancer Res. 51 (1991), 4476-4480.
43. Tracey, K. J., A. Cerami: Tumor necrosis factor: A pleitropic cytokine and therapeutic target. Ann. Rev. Med. 45 (1994), 491-503.
44. Truitt, R. L., C. A. Keever, E. C. Borden: Role of IL-4, IL-6, and IL-12 in cancer therapy. In: DeVita, V. T., S. Hellman, S. A. Rosenberg (eds.): Biologic therapy of cancer. Lippincort, Philadelphia 1995, p. 279-294.
45. Vanhaesebroeck, B., M. Mareel, F. v. Roy, J. Grooten, W. Fiers: Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumor genicity and reduced invasiveness in vivo. Cancer Res. 51 (1991), 2229-2238.
46. Waase, I., M. Bergholz, A. Iglauer: Heterogeneity of tumour necrosis factor production in renal cell carcinoma. Europ. J. Cancer 28 (1992), 1660-1664.
47. Warner, S. J. C., P. Libby: Human vascular smooth muscle cells: Target for and source of tumour necrosis factor. J. Immunol. 142 (1989), 100-109.
48. Weichselbaum, R. R.: Cellular and molecular aspects of human tumor radioresistance. In: DeVita, V. T., S. Hellman, S. A. Rosenberg (eds.): Important advances in oncology 1991. Lippincott, Philadelphia 1991, p. 73-83.
49. Weichselbaum, R. R., M. A. Beckett, D. E. Hallahan, D. W. Kufe, E. E. Vokes: Molecular targets to overcome radioresistance. Semin. Oncol. 11 (1992), 14-20.
50. Williamson, B. D., E. A. Carswell, B. Y. Rubin: Human tumor necrosis factor produced by human B-cell lines: Synergistic cytotoxic interaction with human interferon. Proc. nat. Acad. Sci. (Wash.) 80 (1983), 5397-5401.
51. Wu, S., C. M. Boyer, R. S. Whitaker, A. Berchuck, J. R. Wiener, J. B. Weinberg, R. C. Bast: Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: Monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res. 53 (1993), 1939-1944.
52. Yamauchi, N., H. Karizana, H. Watanabe: Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor. Cancer Res. 49 (1989), 1644-1648.
53. Zimmennan, R. J., B. J. Marafino, A. Chan, P. Landre, J. L. Winkelhake: The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. J. Immunol. 142 (1989), 1405-1409.